Assist. Prof. Dr. Seyed Ehsan Enderami | Regenerative Medicine | Best Academic Researcher Award

Mazandaran University of Medical of Sciences | Iran

Assist. Prof. Dr. Seyed Ehsan Enderami is an Assistant Professor of Medical Biotechnology at Mazandaran University of Medical Sciences, Sari, Iran, with research expertise spanning regenerative medicine, stem cell biotechnology, tissue engineering, gene therapy, and molecular oncology. He obtained his B.Sc. in Laboratory Sciences from Yazd University of Medical Sciences, followed by an M.Sc. and Ph.D. in Medical Biotechnology from Zanjan University of Medical Sciences, where his doctoral thesis focused on generating insulin-producing cells from human induced pluripotent stem cells (iPSCs) through microRNA-based strategies in advanced two- and three-dimensional culture systems. Over the course of his career, Assist. Prof. Dr. Enderami has built a strong scientific record, authoring 94 publications indexed in Scopus, which have collectively garnered 1,916 citations from 1,333 documents, earning him a Scopus h-index of 30 and reflecting the lasting impact of his work. His studies have been featured in leading international journals, including Genes, Journal of Cellular Physiology, Artificial Cells, Nanomedicine and Biotechnology, and Cancer Medicine, covering diverse areas such as scaffold-based tissue engineering, stem cell-derived therapies for diabetes, cancer-related inflammation, neuroregeneration, and bioinformatics approaches to pluripotency. In addition to his prolific research contributions, he is a committed academic mentor and educator, teaching across undergraduate, postgraduate, and doctoral programs in fields such as molecular biology, cell culture, genetic engineering, immunology, and pharmaceutical biotechnology. He has also organized and instructed workshops on stem cell technologies, iPSC technology, and entrepreneurship. With his blend of innovative research, impactful publications, and dedication to teaching, Assist. Prof. Dr. Enderami continues to play a pivotal role in advancing biotechnology and regenerative medicine while training the next generation of biomedical scientists.

Profile: Scopus | Orcid

Featured Publications

• Nassiri Mansour, R., Hasanzadeh, E., Abasi, M., Gholipourmalekabadi, M., Mellati, A., & Enderami, S. E. (2023). The effect of fetal bovine acellular dermal matrix seeded with Wharton’s jelly mesenchymal stem cells for healing full-thickness skin wounds. Genes, 14(4), 409.

• Hosseini, F., Mahdian-Shakib, A., Jadidi-Niaragh, F., Enderami, S. E., Mohammadi, H., Hemmatzadeh, M., … Mirshafiey, A. (2018). Anti-inflammatory and anti-tumor effects of α-L-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model. Biomedicine & Pharmacotherapy, 107, 172–180.

• Hashemi, J., Pasalar, P., Soleimani, M., Khorramirouz, R., Fendereski, K., Enderami, S. E., & Kajbafzadeh, A.-M. (2018). Application of a novel bioreactor for in vivo engineering of pancreas tissue. Journal of Cellular Physiology, 233(5), 3823–3833.

• Ziaei, S., Ardeshirylajimi, A., Arefian, E., Enderami, S. E., Soleimani, M., & Rezaei-Tavirani, M. (2018). Bioinformatics analysis of Ronin gene and their potential role in pluripotency control. Gene Reports, 12, 143–150.

• Hashemi, J., Pasalar, P., Soleimani, M., Arefian, E., Khorramirouz, R., Akbarzadeh, A., … Enderami, S. E. (2018). Decellularized pancreas matrix scaffolds for tissue engineering using ductal or arterial catheterization. Cells Tissues Organs, 205(3–4), 183–195.

• Mahboudi, H., Soleimani, M., Enderami, S. E., Kehtari, M., Ardeshirylajimi, A., Eftekhary, M., & Kazemi, B. (2018). Enhanced chondrogenesis differentiation of human induced pluripotent stem cells by MicroRNA-140 and transforming growth factor beta 3 (TGFβ3). Biologicals, 53, 15–23.

• Enderami, S. E., Soleimani, M., Mortazavi, Y., Nadri, S., & Salimi, A. (2018). Generation of insulin-producing cells from human adipose-derived mesenchymal stem cells on PVA scaffold by optimized differentiation protocol. Journal of Cellular Physiology, 233(5), 3869–3879.

• Jafari, S. M., Panjehpour, M., Aghaei, M., Joshaghani, H. R., & Enderami, S. E. (2017). A3 adenosine receptor agonist inhibited survival of breast cancer stem cells via GLI-1 and ERK1/2 pathway. Journal of Cellular Biochemistry, 118(11), 3768–3777.